Some women with a very early form of breast cancer known as ductal carcinoma in situ (DCIS) can safely skip follow-up radiation therapy after surgery, new research suggests.

Results from a sophisticated genetic test are key to the decision to either undergo or skip radiotherapy, say researchers at Northwestern University in Chicago.

... Full Page

Sydnee Meth survived breast cancer, but she wasn’t prepared for the aftereffects of her treatment.

Doctors removed the lymph nodes from Meth’s right armpit during her second bout with breast cancer in 2014, and as a result she developed a painful condition called lymphedema.

For years, her right arm was so swollen and heavy she c... Full Page

The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication costs too much.

Federal law allows the government to grant patent licenses if taxpayer dollars were used in the development of inventions --... Full Page

The Biden administration has again delayed enacting a ban on menthol cigarettes following intense lobbying from the tobacco industry.

Along with that pressure, other critics of the ban have warned that it might anger Black smokers, who use menthol cigarettes at far higher rates than whites -- just as President Biden gears up to run for re-... Full Page

Games like football, soccer and rugby come to mind when thinking about sports-related concussions.

But a smashing tennis shot could cause a traumatic brain injury if the ball whacks a player’s head, a new study argues.

Concussions can happen if a tennis ball traveling faster than 89 miles per hour hits someone on the head, research... Full Page

Women in the their 50s and 60s who've gone through menopause may be able to safely skip radiation treatment if they're diagnosed with a common form of breast cancer, new research shows.

The study focused on early stage HR+ breast cancers, which comprise the large majority of new cases. In HR+ breast cancer, tumor cells carry receptors for ... Full Page